Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Viela Bio's share price for the quarter that ended in Dec. 2020 was $35.97. Viela Bio's Shares Outstanding (EOP) for the quarter that ended in Dec. 2020 was 54.89 Mil. Therefore, Viela Bio's market cap for the quarter that ended in Dec. 2020 was $1,974.45 Mil.
Viela Bio's quarterly market cap
declined
from Jun. 2020 ($2,370.60 Mil) to Sep. 2020 ($1,539.79 Mil) but then
increased
from Sep. 2020 ($1,539.79 Mil) to Dec. 2020 ($1,974.45 Mil).
Viela Bio's annual market cap
increased
from Dec. 2018 ($0.00 Mil) to Dec. 2019 ($1,374.28 Mil) and
increased
from Dec. 2019 ($1,374.28 Mil) to Dec. 2020 ($1,974.45 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Viela Bio's Enterprise Value for Today is $2,545.22 Mil.
Viela Bio Market Cap Historical Data
The historical data trend for Viela Bio's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Viela Bio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viela Bio's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Viela Bio's Market Cap distribution charts can be found below:
* The bar in red indicates where Viela Bio's Market Cap falls into.
Viela Bio Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Viela Bio's Market Cap for the fiscal year that ended in Dec. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viela Bio (NAS:VIE) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Viela Bio Market Cap Related Terms
Thank you for viewing the detailed overview of Viela Bio's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VIE has been successfully added to your 